Literature DB >> 21051540

Oct1 is a switchable, bipotential stabilizer of repressed and inducible transcriptional states.

Arvind Shakya1, Jinsuk Kang, Jeffrey Chumley, Matthew A Williams, Dean Tantin.   

Abstract

Little is known regarding how the Oct1 transcription factor regulates target gene expression. Using murine fibroblasts and two target genes, Polr2a and Ahcy, we show that Oct1 recruits the Jmjd1a/KDM3A lysine demethylase to catalyze the removal of the inhibitory histone H3K9 dimethyl mark and block repression. Using purified murine T cells and the Il2 target locus, and a colon cancer cell line and the Cdx2 target locus, we show that Oct1 recruits the NuRD chromatin-remodeling complex to promote a repressed state, but in a regulated manner can switch to a different capacity and mediate Jmjd1a recruitment to block repression. These findings indicate that Oct1 maintains repression through a mechanism involving NuRD and maintains poised gene expression states through an antirepression mechanism involving Jmjd1a. We propose that, rather than acting as a primary trigger of gene activation or repression, Oct1 is a switchable stabilizer of repressed and inducible states.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21051540      PMCID: PMC3013004          DOI: 10.1074/jbc.M110.174045

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

1.  The epigenetic magic of histone lysine methylation.

Authors:  Thomas Jenuwein
Journal:  FEBS J       Date:  2006-07       Impact factor: 5.542

2.  Regulation of NF-kappaB-dependent gene expression by the POU domain transcription factor Oct-1.

Authors:  Nathaniel G dela Paz; Simos Simeonidis; Christopher Leo; David W Rose; Tucker Collins
Journal:  J Biol Chem       Date:  2006-12-27       Impact factor: 5.157

3.  Accumulation of NFAT mediates IL-2 expression in memory, but not naïve, CD4+ T cells.

Authors:  Oliver Dienz; Sheri M Eaton; Troy J Krahl; Sean Diehl; Colette Charland; John Dodge; Susan L Swain; Ralph C Budd; Laura Haynes; Mercedes Rincon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-16       Impact factor: 11.205

Review 4.  The human Mi-2/NuRD complex and gene regulation.

Authors:  S A Denslow; P A Wade
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

5.  An inducible enhancer required for Il12b promoter activity in an insulated chromatin environment.

Authors:  Liang Zhou; Aaron A Nazarian; Jian Xu; Dean Tantin; Lynn M Corcoran; Stephen T Smale
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

6.  JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor.

Authors:  Kenichi Yamane; Charalambos Toumazou; Yu-ichi Tsukada; Hediye Erdjument-Bromage; Paul Tempst; Jiemin Wong; Yi Zhang
Journal:  Cell       Date:  2006-04-06       Impact factor: 41.582

7.  A specific CpG site demethylation in the human interleukin 2 gene promoter is an epigenetic memory.

Authors:  Akiko Murayama; Kazuhisa Sakura; Mina Nakama; Kayoko Yasuzawa-Tanaka; Etsuko Fujita; Yukiyo Tateishi; Yinan Wang; Toshikazu Ushijima; Tadashi Baba; Kazuko Shibuya; Akira Shibuya; Yoh-ichi Kawabe; Junn Yanagisawa
Journal:  EMBO J       Date:  2006-02-23       Impact factor: 11.598

8.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

Review 9.  Stability and flexibility of epigenetic gene regulation in mammalian development.

Authors:  Wolf Reik
Journal:  Nature       Date:  2007-05-24       Impact factor: 49.962

10.  The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis.

Authors:  Claudia Scholl; Dimple Bansal; Konstanze Döhner; Karina Eiwen; Brian J P Huntly; Benjamin H Lee; Frank G Rücker; Richard F Schlenk; Lars Bullinger; Hartmut Döhner; D Gary Gilliland; Stefan Fröhling
Journal:  J Clin Invest       Date:  2007-03-08       Impact factor: 14.808

View more
  36 in total

Review 1.  CHD chromatin remodelers and the transcription cycle.

Authors:  Magdalena Murawska; Alexander Brehm
Journal:  Transcription       Date:  2011-11-01

2.  Variants in an Hdac9 intronic enhancer plasmid impact Twist1 expression in vitro.

Authors:  Tyler E Siekmann; Madelyn M Gerber; Amanda Ewart Toland
Journal:  Mamm Genome       Date:  2015-12-31       Impact factor: 2.957

Review 3.  The Oct1 transcription factor and epithelial malignancies: Old protein learns new tricks.

Authors:  Karina Vázquez-Arreguín; Dean Tantin
Journal:  Biochim Biophys Acta       Date:  2016-02-10

4.  Cellular transcription factor Oct-1 interacts with the Epstein-Barr virus BRLF1 protein to promote disruption of viral latency.

Authors:  Amanda R Robinson; Swee Sen Kwek; Stacy R Hagemeier; Coral K Wille; Shannon C Kenney
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

5.  OCT-1 overexpression is associated with poor prognosis in patients with well-differentiated gastric cancer.

Authors:  Sang-Ho Jeong; Young-Joon Lee; Bok-Im Cho; Woo-Song Ha; Sang-Kyung Choi; Eun-Jung Jung; Young-Tae Ju; Chi-Young Jeong; Gyung Hyuck Ko; Jiyun Yoo; Soon-Chan Hong
Journal:  Tumour Biol       Date:  2014-02-25

6.  Efficient chromatin immunoprecipitation using limiting amounts of biomass.

Authors:  Dean Tantin; Warren P Voth; Arvind Shakya
Journal:  J Vis Exp       Date:  2013-05-01       Impact factor: 1.355

7.  Pluripotency transcription factor Oct4 mediates stepwise nucleosome demethylation and depletion.

Authors:  Arvind Shakya; Catherine Callister; Alon Goren; Nir Yosef; Neha Garg; Vahid Khoddami; David Nix; Aviv Regev; Dean Tantin
Journal:  Mol Cell Biol       Date:  2015-01-12       Impact factor: 4.272

8.  Impact of histone demethylase KDM3A-dependent AP-1 transactivity on hepatotumorigenesis induced by PI3K activation.

Authors:  T Nakatsuka; K Tateishi; Y Kudo; K Yamamoto; H Nakagawa; H Fujiwara; R Takahashi; K Miyabayashi; Y Asaoka; Y Tanaka; H Ijichi; Y Hirata; M Otsuka; M Kato; J Sakai; M Tachibana; H Aburatani; Y Shinkai; K Koike
Journal:  Oncogene       Date:  2017-07-10       Impact factor: 9.867

9.  Regulation of Oct1/Pou2f1 transcription activity by O-GlcNAcylation.

Authors:  Jinsuk Kang; Zuolian Shen; Jae-Min Lim; Hiroshi Handa; Lance Wells; Dean Tantin
Journal:  FASEB J       Date:  2013-04-11       Impact factor: 5.191

10.  Vitamin C promotes maturation of T-cells.

Authors:  Jared Manning; Birgitta Mitchell; Daniel A Appadurai; Arvind Shakya; Laura Jean Pierce; Hongfang Wang; Vincent Nganga; Patrick C Swanson; James M May; Dean Tantin; Gerald J Spangrude
Journal:  Antioxid Redox Signal       Date:  2013-02-05       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.